NCDC refutes Lancet AMR study, says high colonisation not infection risk

The NCDC challenged a Lancet study on high MDRO colonisation in Indian ERCP patients, stating colonisation infection and ...
ET HealthWorld

India shows lower MRSA, VRE rates than US and Europe despite MDR findings: Official sources

Official sources reveal that India has lower rates of MRSA and VRE compared to the US and Europe, despite a significant ...

India shows lower MRSA, VRE rates than US, Europe despite high colonisation

The National Centre for Disease Control (NCDC) has clarified claims made in a study published in The Lancet, which reported a ...

India’s drug-resistant infection rates lower than U.S., Europe despite higher microbial colonisation

A new study reveals India's drug-resistant infection rates are lower than those in the U.S. and Europe, despite microbial ...

What Are Superbugs? The Bacteria Behind India's Antibiotic Resistance Crisis, Explained

India is the epicentre of a full-blown superbug crisis fuelled by antibiotic resistant bacteria, according to a recent study ...

Over 80% Of Indian Patients Carry Multidrug-Resistant Organisms, Flags Lancet Study

More than 80 per cent of Indian patients carry multidrug-resistant organisms (MDROs) -- the highest globally, according to an ...
Mid-Day

Prevalence of multidrug-resistant organisms highest in Indian patients: Study

A study reveals over 80 pct of Indian patients carry multidrug-resistant organisms, placing India at the centre of a growing ...

India's Superbug Crisis: Lancet Data Misinterpreted, Says Government Body

The National Centre for Disease Control (NCDC) says the findings of the recent Lancet study reflects bacterial colonisation, ...
Bangalore Mirror

A bitter pill to swallow

Widespread availability of over-the-counter antibiotics and misuse at home are main drivers of antibiotic resistance, says ...